International Cannabis Weekly: 387

JAZZ PHARMA DROPS LAST DEFENDANT FROM EPIDIOLEX PATENT SUIT

Jazz Pharmaceuticals Inc. has reached an agreeement to dismiss all claims and counter claims with the last remaning defendant in its consolidated lawsuits over patents covering its epilespy treatment Epidiolex, according to a filing from the company in New Jersey federal court.

READ MORE  »

EUROPEAN CANNABIS WEEK RETURNS, UNITING LONDON AND BERLIN IN LANDMARK EVENT

READ MORE »

SPAIN’S ‘FEEBLE’ MEDICAL CANNABIS PROPOSALS DISAPPOINTING FOR PATIENTS

READ MORE »

• Medical marijuana remains illegal in France despite positive trial results and patient demand.
• Tilray expands medical cannabis portfolio in Germany, strengthening its European market presence.
• Switzerland moves closer to full cannabis legalisation as reforms start to gain momentum.
• Malta to start to allow cannabis associations to sell resin and rosin later this year.
• 99% of cannabis in France still comes from the black market, new research finds.
• UK risks is poised to miss out on “immense” £1 billion cannabinoid industry opportunity.

DOWNLOAD FOR FREE »

• Hawaii House unexpectedly shelves recreational cannabis bill in major legislative reversal.
• Arkansas House panel approves bill to fund school meals using marijuana tax revenue.
• Florida bill proposes expanding medical marijuana access for out-of-state patients and new conditions.
• Nevis Brands partners with Drecisco Farms to launch major cannabis brand in Illinois.
• Illinois cannabis sales surged in 2024, reflecting strong consumer demand and market growth.
• Major US cannabis company reports strong Q4 earnings, boosting investor confidence.
• Minnesota launches program to support communities impacted by past cannabis prohibition.
• Ethos Cannabis launches exclusive new Huny edibles line in Pennsylvania dispensaries.

SIGN UP FOR EARLY ACCESS »

• Rubicon Organics secures key certification for international cannabis export operations.
• MediPharm Labs cancels planned sale of Ontario cannabis facility to Kensana Health.
• Canopy Growth reports third-quarter fiscal 2025 results, revealing financial performance trends.
• Canadian cannabis company Aphria reaches settlement agreement to resolve ongoing dispute.
• Aurora Cannabis reports $88 million in net revenue for third-quarter fiscal of 2025.
• Aurora signs $27 million supply agreement with SNDL to expand cannabis distribution.

• BPA president says training standards must be set before issuing cannabis licences.
• Antigua’s cannabis industry undergoes major reforms, boosting sector growth in 2024.
• Ecuador emerges as a potential hemp powerhouse in the Latin American market.
• Brazil’s Supreme Court to hold first hearing on delaying hemp regulation deadline.

• Australia’s medical cannabis market projected to outpace Europe’s top-performing regions.
• Medtec Pharma pioneers freeze-dried cannabis production using homegrown Australian crops.
• MediGrowth Australia launches crowdfunding campaign to accelerate market expansion.

• Gqeberha welcomes R1 billion MediGrow cannabis project, strengthening South Africa’s industry.
• Innocan Pharma’s liposomal CBD injection provides breakthrough pain relief for osteoarthritic donkey.